Consortium members are expected to have access to the dataset by early 2027, and there are plans to add more complex antibody ...

Merck acquires global rights to SciBrunch Therapeutics’ SPR2015, a preclinical oral KRAS G12D inhibitor, in a deal worth up ...

The findings by scientists at NYU Abu Dhabi provide new insight into how cells respond when cancer-causing genes are ...

AI-guided structural modeling and proteomics identified molecular glues that degrade VAV1, a potential target in blood cancers and autoimmune diseases.

Nektar Therapeutics won its legal dispute with Eli Lilly over rezpegaldesleukin, but the court victory failed to deliver a ...

Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to ...

Researchers at the Nano Life Science Institute at Kanazawa University in Japan say they have directly visualized how enzymes ...

A slow-release liposome system delivered local anesthesia for weeks in rats, potentially enabling new approaches to pain ...

The results of a study by researchers at Texas Children’s Duncan Neurological Research Institute (Duncan NRI), at Baylor ...

The finding may make it possible to launch saRNA vaccines faster for use in gene therapy, cancer immunotherapy, and protein replacement.

JNC is using BPI 2026 to spotlight Cellufine and its emerging MLP chromatography media, developed to address purification ...

Researchers hope findings could help lead to strategies for creating stem cell-derived dopamine-producing neurons that can be ...